Surviving a CMS-Mandated Independent Validation Audit (IVA): 150 Days and Counting

Similar documents
1/6/2017. Surviving a CMS-Mandated Independent Validation Audit (IVA): 150 Days and Counting. Agenda. 150 Days and Counting

All Medicare Advantage Plans, Prescription Drug Plans, Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Organizations

Frequently Asked Questions Last Updated: November 16, 2015

American Health Lawyers Association Medicare Advantage and Part D: Plan Provider Relationships in Light of Recent CMS Enforcement Actions

Medicare Parts C & D General Compliance Training

Health Care Compliance Association: Medicare Part D Compliance Conference

Tough Questions Under the CMS Compliance Program Guidelines

Compliance Program. Health First Health Plans Medicare Parts C & D Training

FDR Compliance Guide. Paramount

Introduction to Medicare Parts C and D

CMS Proposed Rulemaking For The Medicare Advantage And Medicare Prescription Drug Programs

MEDICARE COMPLIANCE PROGRAM GUIDE F I R S T T I E R, D O W N S T R E A M, A N D R E L A T E D E N T I T I E S ( F D R )

Agent Medicare Sales ATRIO Health Plans Oversight

CMS Part D UPDATES. Kim Brandt Director, Program Integrity Centers for Medicare & Medicaid Services

Medicare Part D: Retiree Drug Subsidy

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training. Developed by the Centers for Medicare & Medicaid Services

Planning Survey Questionnaire (PSQ)

6 KEY QUESTIONS TO ENSURE EFFECTIVE MANAGED CARE ADMINISTRATION AND OVERSIGHT

ADVANCE BENEFICIARY NOTICE OF NONCOVERAGE

FDR. Compliance Guide

Frequently Asked Questions (FAQs) for First Tier, Downstream and Related Entities (FDRs)

MMP (CalMediconnect) Community Health Group. and. First Tier, Downstream & Related Entity

Medications can be a large

Introductory Guide to Medicare Part C and D

Compliance and Fraud, Waste, and Abuse Awareness Training. First Tier, Downstream, and Related Entities

SHARP HEALTH PLAN MEDICARE ADVANTAGE POLICY AND PROCEDURE Product Line (check all that apply):

Don t t Scuttle the Ship: Navigating the Regulatory Ocean in Pursuit of Part D Marketing Compliance

PPACA and Health Care Reform. A Chronological Guide to Changes and Provisions Affecting Employee Benefits Plans and HR Administration

Required CMS Contract Clauses Revised 8/28/14 CMS MCM Guidance Chapter 21

STRIDE sm (HMO) MEDICARE ADVANTAGE Fraud, Waste and Abuse

Federal Bank Secrecy Act / Anti-Money Laundering (BSA/AML) Oversight

Medicare Advantage and Part D Contract Compliance & Oversight Overview

Continuation of the Prescription Drug Event (PDE) Reports and PDE Analysis Reporting Initiatives for the 2014 Benefit Year

Answers to Frequently Asked Questions

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

Part D Administrative Contract Flowdowns

Building Clinical Trial Revenue Integrity Compliance Through Auditing and Understanding Payer Requirements

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

Overview of October 24, 2013 Final Rule on Program Integrity: Exchange, Premium Stabilization Programs, and Market Standards

MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers

Maintaining your 403(b) plan s tax-favored status under EPCRS

Linking Performance and Compliance: How Part D Quality Measures Relate to Plan Performance

Frequently Asked Questions (FAQs) Medicare Part C Policy Mailbox Division of Policy, Analysis, and Planning (DPAP) Last Updated: November 6, 2017

John Smith, DO renders a service to patient Jones, bills her insurance company $100 and is paid $1. When can he send Jones a balance bill for $99?

GOALS OF THIS PRESENTATION HOW WE GOT HERE WHERE WE ARE MANDATORY COMPLIANCE REQUIREMENTS LESSONS FROM MANDATORY COMPLIANCE IN NEW YORK MY PREDICTIONS

COMPLIANCE; It s Not an Option

Part D Performance Audits - Formulary Administration

National Policy Library Document

Eligibility and Enrollment in the Medicare Prescription Drug Program

SETTING A STANDARD FOR GP COMPLIANCE

Issue brief: Medicaid managed care final rule

The wait is over HHS releases final omnibus HIPAA privacy and security regulations

Corporate Legal Policy

Correcting Plan Errors Using IRS Voluntary Correction Programs

CMS Final Rule: Medicaid Managed Care The Medicaid Mega-Reg

20. CLAIMS PROCESSING. A. Claims Processing APPLIES TO:

2018 Medicare Part D Transition Policy

Commitment to Compliance

Effective Collaboration Between Compliance Officers and State and Federal Law Enforcement OBJECTIVES

SPD Administrative Information

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

The "sometimes" would not be used to describe separate patient encounters with different providers.

Coverage Determinations, Appeals and Grievances

Your Medicare Prescription Drug Coverage as a Member of Medi-Pak Rx Premier

Developed by the Centers for Medicare & Medicaid Services Issued: February, 2013

r Current BCBSIL clients

RAC Audits, Extrapolation and Defensive Strategies

2017 National Training Program

Goals of the Presentation. ACO Compliance Planning: Navigating 1/22/2016. Disclaimer

Martin s Point Generations Advantage Policy and Procedure Form

Compliance Fraud, Waste and Abuse HIPAA Privacy and Security

Program Integrity in Tennessee: TennCare Oversight Activities - Coordination

ACO: Shared Savings Model

Application for Medicare Supplement New Hampshire Anthem Blue Cross and Blue Shield 1155 Elm St., Ste. 200 Manchester, NH

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

Code of Conduct/Ethics Policies and Procedures

ABN Changes for 2013

Agent Instruction Sheet for the MRA Plan Document

IRS Enforcement of Employer Mandate

Reimbursement and Funding Methodology For Demonstration Year 11. Florida s 1115 Managed Medical Assistance Waiver. Low Income Pool

MEDICARE PLAN PAYMENT GROUP

Medicare Minute Teaching Materials - June 2018 How to Afford Your Part D Drug Costs

What to Expect When Contracting with MCOs

Key Elements of Health Care Reform for Employers

Signature of company officer or authorized representative

DRAFT Premium Adjustment Percentage

Each MCO, PIHP, and PAHP must have a grievance and appeal system in place for their enrollees.

Medicare Advantage High Level Training

Retiree Drug Subsidy Update and RDS Program Oversight

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

2019 Transition Policy

Transition Guidance for Non-Special Needs Enrollees in MA Special Needs Plans Under the Disproportionate Share Policy

Shared Savings Program ACOs and Payors: Opportunities and Challenges in a New Era of Accountable Care

National Policy Library Document

PI Compensation: Methods, Documentation, and Execution

PI Compensation: Methods, Documentation, and Execution

THE MEDICARE R x DRUG LAW

TOP 10 METRICS TO MAXIMIZE YOUR PRACTICE S REVENUE

Legal Implications of Concierge Medical Practice for Health Plan Providers and Enrollees

Auditing RACphobia. Lamon Willis, CPCO, CPC-I, CPC-H, CPC AHIMA-Approved ICD-10-CM/PCS Trainer Xerox Healthcare Consultant

Transcription:

ATTAC Consulting Group, LLC Strategic Health Law PLLC Surviving a CMS-Mandated Independent Validation Audit (IVA): 150 Days and Counting Anne Crawford, ATTAC Consulting Group Elizabeth Lippincott, Strategic Health Law Health Care Compliance Association Managed Care Compliance Conference January 31, 2017 Agenda Key Considerations When Determining Clean Period and Managing 150 Calendar Deadline to Start IVA Managing First Tier Entities and Downstream Entities How To Incorporate Lessons Learned From Plans Who Have Been Through IVAs After the Audit Civil Monetary Penalty Calculations Contracts with First Tier Entities and use of legal counsel in Program Audits and IVAs Surviving CMS-mandated IVA Audits 2 1

150 Days and Counting Submit Corrective Action Plans (CAPs) via HPMS for any conditions noted- Within 3 business days of formal notification for ICARs Within 30 business days from issuance of final audit report for CARs CMS accepts CAPS 150 days to undergo independent validation Surviving CMS-mandated IVA Audits 3 Key Consideration When Determining Clean Period Estimate projected CAP completion dates for planning purposes and estimation of when clean operating period would begin for various operating areas Plan must operate in its clean period-- For Part C domains at least 60 days to allow for full cases (start/end) to complete For Part D domains at least 30 days to allow for full cases (start/end) to complete Validation audits may be staggered in time across domains, they do not have to all occur at the same time Surviving CMS-mandated IVA Audits 4 2

Independent Validation Audits and FDR Oversight Risk CMS Doesn t Differentiate Between a Plan and its FDRs Issues With FDR Compliance Have Had Significant Impact On Sponsors Bad Audit Universe Data (Data Capture) Undetected Non-Compliance Invalid Data Submission (IDS) Surviving CMS-mandated IVA Audits 5 FDR Oversight Through Universe Review Annual reviews of FDR have proven very ineffective you simply can t see what s happening on a routine basis Best Practice: Routine case reviews pulled from universes Universe Data from delegates should be tested, i.e. is the data in the universe what s supposed to be there Surviving CMS-mandated IVA Audits 6 3

Program Audits and FDR Oversight Lack of FDR Knowledge Training Plans have assumed that FDRs know how to implement things and have read the manuals and have Medicare experts. Plans may audit / test outcomes but don t test the pre-cursors. Data Capture in Systems (e.g. data definition & actual mail date capture) Internal FDR metrics and monitoring for key performance issues Key Issues: Failed Universes (incomplete, data format etc.) Denial Standards (Plan s vs. FDRs) Denial Notices (unclear, not specific and not accurate) Notice Requirements (To beneficiaries and providers) Surviving CMS-mandated IVA Audits 7 Organization/Coverage Determinations, Appeals and Grievances Why are ODAG and CDAG so important? These area focus on the beneficiary receiving eligible Parts C & D (medical & drug) benefits. Non-compliance in these areas can adversely affect (or has the substantial likelihood of adversely affecting) one or more beneficiaries. Non-compliance in these areas has the potential to cause beneficiary harm. Surviving CMS-mandated IVA Audits 8 4

How To Incorporate Lessons Learned From Plans Who Have Been Through IVAs Surviving CMS-mandated IVA Audits 9 Biggest Challenges in Managing an IVA Moving universes to a data analytic team for managing several hundred delegated universes & formats, which must be consolidated into one Our PBM Managing internal work teams with competing priorities Surviving CMS-mandated IVA Audits 10 5

Lessons Learned---Process Improvements Need an automated process on Plan s end to validate universes Have the A team presenting to the IVA auditors Keep IVA focused on CMS findings being validated Transparency is important CMS does not expect perfection If it isn t documented; it wasn t done Helps to have POC identified on each end Need to account for time zone differences Surviving CMS-mandated IVA Audits 11 Advice for Plans Audited in 2016 Who Will Go Through IVA Start the plan for the IVA the day of your CMS audit exit Look for experienced auditors who mirror CMS Work with the IVA auditor on the planning of the audit Make sure you have extensive documentation Surviving CMS-mandated IVA Audits 12 6

Enforcement Actions: 2015 CMPs and Intermediate Sanctions 2015 Part C and Part D Program Audit and Enforcement Report, September 6, 2016 Civil Monetary Penalties (CMPs) Maximums Penalties imposed have been relatively restrained compared with CMS maximum authority. Penalty amounts Up to $25,000 ($36,794 adjusted for inflation) per finding that has adversely affected an enrollee (or substantial likelihood of adverse effect) Up to $25,000 ($36,794 adjusted for inflation) per enrollee adversely affected (or substantial likelihood of adverse effect) Up to $10,000 ($14,718 adjusted for inflation) for each week that deficiency remains uncorrected after notice of CMS determination Authority to Impose CMPs: 42 CFR 422.760, 423.760; 42 CFR 102.3 (inflation adjustments) Trends in CMS Audits and Enforcement Actions 14 7

CMS 2017 CMP Methodology Key language: The methodology described in this document does not limit CMS authority to impose any penalty that is permissible under the law. Used primarily to calculate deficiencies detected during routine Program Audits Implicit assumption of good faith mistakes Avoid prospective cost-benefit risk calculations using CMP Methodology amounts Standard formula Per enrollee (CMP amount X # of affected enrollees) or Per determination basis (CMP amount X # of affected contracts) Trends in CMS Audits and Enforcement Actions 15 Beneficiary Impact Submit mitigating evidence in response to Draft Audit Report Beneficiary impact At least one beneficiary was directly adversely affected Substantial likelihood of adversely affecting enrollee(s) CMS takes the position that it has authority to determine that deficiency had the potential to adversely affect an enrollee even if sponsor can show evidence that it did not (e.g. paid claim) (see p. 4 of 12/15/16 CMP Methodology) Trends in CMS Audits and Enforcement Actions 16 8

Standard Penalties $200 per enrollee Inappropriate delay/denial of medical services or drugs Incorrect premium charged or unnecessary costs incurred $25 per enrollee Inaccurate or untimely plan benefit information e.g. ANOC and/or EOC $20,000 per violation/per contract Invalid data submission (failure to provide valid enrollee universes) For other per contract violations, CMS uses maximum amount permitted by regulation Trends in CMS Audits and Enforcement Actions 17 Aggravating and Mitigating Factors Program Audit CMPs Most sponsors received CMPs for non-compliance in the program areas of FA, CDAG, and ODAG because their actions adversely affected (or had the substantial likelihood of adversely affecting) one or more enrollees. CMS may either increase or decrease a sponsor s CMP by applying aggravating or mitigating factors to certain deficiencies Aggravating Factors Mitigating Factors e.g., involved drugs where treatment should not be delayed, expedited cases, a prevalence of failed audit samples, the existence of a top-5 common findings condition, and/or a history of prior offense. e.g., beneficiary received the drug on the same day or the enrollment based penalty cap per condition of non-compliance were reached. 9

Per Enrollee Aggravating Penalty Amounts Inappropriate delay/denial of medical services or drugs Expedited decisions - $100 Prior offense ($100 for first; $1,000 for two or more) Violation among top conditions in Annual Audit Report - $100 Incorrect premiums or cost sharing Inappropriate out-of-pocket cost exceeding $100 - $100 Prior offense - $100 for first; $1,000 for two or more Violation among top conditions in Annual Audit Report - $100 Untimely or inaccurate plan benefit information Prior offense - $15 ANOC/EOC/errata after Dec. 31 - $15 Trends in CMS Audits and Enforcement Actions 19 Caps on Penalties Based on Total Enrollment Enrollment of Parent Organization CMP Violation Limit (Per Violation) Below 1,000 $50,000 1,000 4,999 $100,000 5,000 19,999 $200,000 20,000 49,999 $300,000 50,000 99,999 $400,000 100,000 249,000 $500,000 250,000 499,999 $1,000,000 500,000 2,999,999 $1,500,000 3,000,000 or more $2,000,000 Trends in CMS Audits and Enforcement Actions 20 10

First Tier Entity Contracts Familiarity with current CMS Audit Protocols Ability to generate accurate and compliant universes timely Audit support personnel with appropriate expertise Indemnification for violations leading to CMPs Trends in CMS Audits and Enforcement Actions 21 Using Counsel During Audit and Validation Behind the scenes Review CAPs and other written responses Consult on concerns and development of narrative Trial runs of tracers Trends in CMS Audits and Enforcement Actions 22 11

ATTAC Consulting Group, LLC Strategic Health Law PLLC Anne Crawford acrawford@attacconsulting.com 412.849.6623 Elizabeth Lippincott elippincott@strategichealthlaw.com 919.967.9845 Surviving CMS-mandated IVA Audits 39 12